Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020

Wei, Yuxuan; Zhang, Yichen; Xu, Ziyue; Wang, Guoan; Zhou, Yue; Li, Huangqianyu; Shi, Luwen; Naci, Huseyin; Wagner, Anita K.; Guan, Xiaodong

doi:10.1016/j.lanwpc.2024.101055

The Lancet Regional Health - Western Pacific

2024

DOI: 10.1016/j.lanwpc.2024.101055

|View full text |Cite

Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020

Yuxuan Wei,

Yichen Zhang,

Ziyue Xu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2025

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Expedited Approval of Urgently Needed Drugs in China

Wei,

Zhang,

et al. 2025

JAMA Health Forum

View full text Add to dashboard Cite

show abstract

Expedited Approval of Urgently Needed Drugs in China

Wei,

Zhang,

et al. 2025

JAMA Health Forum

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020

Cited by 1 publication

References 44 publications

Expedited Approval of Urgently Needed Drugs in China

Expedited Approval of Urgently Needed Drugs in China

Contact Info

Product

Resources

About